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joints in the aspect of age-related osteoarthritis:
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Young Hoon Hong1* and Eun Jung Kong2Abstract
Background: This study investigated 18F-fluorodeoxyglucose (18F-FDG) uptake at knee joints for determination of
metabolic alteration in association with the advance of age and joint degeneration such as osteoarthritis (OA).
Methods: A total of 166 knees from 83 healthy persons who presented for routine health examination and
positron emission tomography-computed tomography (PET/CT) were enrolled in this study. History of knee OA and
joint symptoms and signs were reviewed. The maximum standardized uptake values (SUVmax) of cartilage and
mean SUV (SUVmean) between the epiphyseal plates of femur and tibia were evaluated at knee joints. Assessment
of radiological bony changes was performed using the Kallgren-Lawrence (K/L) grading system with reconstructed
CT images of the knee. The joint symptoms and signs were counted and used for diagnosis of clinical and
radiological OA of the knee.
Results: The SUVmean of the knee joints showed a remarkable increase with aging in females (r = 0.503, p < 0.01).
Remarkable changes of SUVmean were observed with history of OA (p < 0.01). The SUVmean of joint and the intra-
articular SUVmax showed higher values in clinical and radiological OA than in normal joints (p < 0.01). Joint-SUVmean
showed significant correlation with OA severity graded according to K/L score (p < 0.05). The intra-articular SUVmax
showed a significant increase in symptomatic joints, indicating OA in correlation with the joint-SUVmean (p = 0.01).
Conclusions: The increasing 18F-FDG uptakes of knee joints showed agreement with aging in females and clinical and
radiological knee OA, indicating that the metabolic alterations were consistent with diagnosis and demographic aspect
of OA as a surrogate marker for degeneration of the knee in association with aging.
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OA is usually characterized by painful joints, which may
accompany subchondral sclerosis, joint space narrowing,
and osteophytosis in association with cartilage degener-
ation. These changes may lead to joint destruction, loss
of joint function, and joint failure. Aging is the most
important risk factor for primary OA not caused by
injury or disease, and almost 80% of people older than
75 years of age present with OA, one of the most com-
monly occurring diseases in the elderly [1]. However, it* Correspondence: yhhongdr@yahoo.co.kr
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distribution, and reproduction in any mediumremains unclear what occurs in the joints with aging and
how aging affects the joints and elicits OA.
Regarding the pathogenesis of OA, it is generally
accepted that if physical stress to a joint is sufficient to de-
nature articular cartilage matrix, synthesis of proteoglycans
and collagen decreases, making the joint vulnerable to
stress [2]. As cartilage wears out, increased stress to the
joint may lead to development of a micro-fracture in the
subchondral bone. Healing processes following micro-
fracture result in bony sclerosis and stiffness, compromis-
ing capacity to resolve stress. In a vicious manner, the
insulted joints fall into irreversible progression to overt OA
[3]. However, metabolic alterations in cartilage may be
associated with vulnerability of the joint to stress intral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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ing aging may contribute to development of OA [4].
18F-FDG is one of the most popular radiopharmaceuti-
cals used for PET scans and 18F-FDG uptake has been
reported to be highly sensitive in detection of metabolic
alterations in some skeletal disorders [5-8]. Intra-articular
SUVmax and joint-SUVmean of 18F-FDG on PET/CT
were measured and calculated at knees for determination
of metabolic changes of the joints in association with
aging, grade of bony changes, and presence of clinico-
laboratory and radiological knee OA, as defined by the
American College of Rheumatology (ACR).
Methods
This study was designed to evaluate changes of 18F-FDG
uptake on PET and K/L grades on CT in 166 knee joints
from 83 healthy persons (42 males and 41 females). The
study was conducted according to the code of ethics of the
World Medical Association (Declaration of Helsinki) and
all of the procedures followed were approved by the ethical
committee of Yeungnam University Medical Center.
Case procurement
All cases presenting for routine medical examination and
whole body fusion PET/CT between 2004 and 2010 were
subjected to this study, regardless of joint problems. Any
case showing abnormalities on laboratory tests, such as a
high erythrocyte sedimentation rate (ESR) and high
rheumatoid factor (RF), history of diabetes, malignancy
and joint trauma, including surgery, and other metabolic
or inflammatory diseases was excluded prior to undergo-
ing PET/CT. Medical history for knee OA was reviewed,
and pain, stiffness, crepitus, bony tenderness, and enlarge-
ment of each knee were counted from 0 to 5 in total. Body
weight, height, and body mass index (BMI) were measured
for the standard uptakes of 18F-FDG and evaluated in
terms of OA as well.
Integrated 18F-FDG PET/CT scan
All patients fasted for at least 6 h prior to undergoing
PET/CT (DST or DVCT, GE Medical system, Milwaukee,
USA). The serum glucose level was measured to ensure
that the result was <200 mg/dL. Sixty to 90 minutes after
intravenous injection of 8.14 MBq/kg of 18F-FDG, whole-
body PET/CT scanning was performed. CT images (120
mAs, 140 kVp, and a section width of 3.75 mm) were
acquired without breath-holding instructions. The PET
emission scan was obtained immediately following acqui-
sition of CT scan, without change in the patient’s position.
Image acquisition for whole body PET/CT was performed
separately from the vertex to the mid-thigh in eight to 10
bed positions, and then from mid-thigh to toe in five to
six bed positions with an acquisition time of 2.5 to 3 min
for each bed position. The attenuation corrected 18F-FDG-PET images were reconstructed using the CT data with an
ordered-subset expectation maximization algorithm. The
attenuation-corrected PET images, CT images, and fused
PET/CT images displayed as coronal, sagittal, and trans-
axial slices were viewed on a workstation (Advanced
workstation 4.4, GE Healthcare). An experienced nuclear
medicine physician, who was not aware of the patient’s
clinical history or recent radiographic data, reviewed and
interpreted the PET/CT images three times. For semi-
quantitative analysis, the regions of interest (ROIs) were
delineated on trans-axial images, and the maximum and
mean standardized uptake values (SUVs) were calculated
on the workstation. The SUVs were acquired using the
attenuation-corrected images, the amount of injected 18F-
FDG, body weight of each patient, and cross-calibration
factors between 18F-FDG-PET and the dose calibrator.
SUV ¼ðdecaycorrected measured activity
mCi=g½ = administered dose mCi½ ð Þ
=patient weight g½ Þ
The average value and the highest value in the ROIs were
defined as the SUVmean and SUVmax, respectively. Joint-
SUVmean and intra-articular SUVmax were adopted in
this study because discrimination of joint structures is diffi-
cult, and determining which structure is responsible for
OA pathology is extremely difficult with PET and CT im-
ages. The joint-SUVmean was obtained from the minimal
area between epiphyseal plates of femur and tibia, includ-
ing intra-articular space and subchondral bones of knee
joints (Figure 1A, green box). The highest 18F-FDG uptake
of intra-articular space was determined as intra-articular
SUVmax in the zone delineated by crooked lines within
the green box for joint-SUVmean, which included cartilage,
synoviums, ligaments, menisci, and synovial fluid, except
for the epiphyseal parts of femur and tibia, and bony part
of patella. Blue rectangles indicate the points of the highest
SUV of the intra-articular space (Figure 1A).
CT image analysis
Non-contrast-enhanced CT images (120 mAs, 140 kVp)
were acquired in helical mode with 3.75 mm slice thick-
ness. As for knee joints, the tomographic CT images were
reconstructed and assessed according to the procedures
outlined by Johnston JD et al. [9]. All reconstructed CT
images were evaluated in a blind manner by a PET/CT
specialist in axial, coronal, and sagittal views for the pres-
ence and degree of joint space narrowing and osteophytes
in medial-, lateral femorotibial joints and femoropatellar
joint from the knee cap to popliteal fossa at an interval of
1 mm (Figure 1B). Intraobserver reliability was 0.78 with
moderate agreement. Subsequently, joint space narrowing
and osteophytosis were graded from 0–IV using the
Kallgren-Lawrence (K/L) system [10]; no abnormal
Figure 1 Joint-SUVmean was measured at the ROIs indicated by the green boxes, which included the minimal area between the
epiphyseal plates of the femur and tibia in the trans-axial, coronal, and sagittal planes. The blue rectangles indicate the points of the
highest SUV of intra-articular space, the ROIs for intra-articular SUVmax are precisely delineated by crooked lines within the green box for joint-
SUVmean. The point of intra-articular SUVmax was confirmed in trans-axial, coronal, and sagittal slices (A). Coronal-reconstruction CT images were
arranged in the anterior-posterior view of knees for K/L grading (B).
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space narrowing but suspicious osteophytes, grade I; min-
imal joint space narrowing and definite osteophytes, grade
II; joint space less than 3 mm, severe intra-articular
irregularity, and prominent osteophytes, grade III; no vis-
ible joint space and severe sclerosis, grade IV.
Statistical analysis
Statistical analysis was performed using SPSS program
version 12. Cohen’s kappa test was used for determination
of intraobserver variation. Independent sample t test, one
way ANOVA test, Pearson’s correlation test, and Linear
regression analysis were used for parametric analysis and
Mann–Whitney test, Kruskal-Wallis test, and Spearman’s
test were used for non-parametric analysis, with a confi-
dence interval of 95% and a p value < 0.05.
Results
18F-FDG uptake and radiological OA of knee joints
Joint mean and intra-articular SUVmax on PET scan were
evaluated according to K/L grade (Figure 1B). Thirty four
knee joints were K/L grade 0, 61 were grade I, 38 weregrade II, and 33 were grade III, and no cases of grade IV
were observed. Mean age of each grade was 46.7±11.3 for
grade 0, 55.1±11.5 for grade I, 58.6±10.5 for grade II, and
60.6±8.9 for grade III, respectively; significantly older
mean age was observed with a higher grade of bony
changes (p < 0.01). Body weight, height, and BMI did not
differ among the groups. The mean and max SUV in the
group of grade 0 were 1.42 ± 0.36 and 0.85 ± 0.18, respect-
ively; 1.55 ± 0.45 and 0.88 ± 0.20, respectively, in grade I;
1.61 ± 0.58 and 0.96 ± 0.19, respectively, in grade II; 1.70 ±
0.51 and 0.97 ± 0.22, respectively, in grade III. Knees with
a higher K/L grade showed higher joint-SUVmean; a sig-
nificant increase of joint-SUVmean was observed among
the groups (p < 0.05), but not for intra-articular SUVmax
(Table 1).
Knees with K/L grade 0 and I can be classified as non-
OA radiographically, and the SUVmean and intra-
articular SUVmax of the non-OA group (n = 95, 0.87±0.19
and 1.50±0.42, respectively) were compared with those of
the radiological OA (K/L grade II, III, and IV [n = 71],
0.96 ± 0.20 and 1.67 ± 0.55, respectively). The joint-
SUVmean and intra-articular SUVmax were higher in
Table 1 The joint-SUVmean and intra-articular SUVmax of the knees according to K/L grades
n Age (yr) BW (kg) HT(cm) BMI (kg/m2) SUVmax SUVmean
Knee joints Total 166 55.3±11.7 62.7±11.7 162.9±8.6 23.5±3.2 1.58 ± 0.49 0.91 ± 0.20
Male 82 55.7 ± 12.1 69.3±11.1** 169.5±6.2** 24.1±3.1** 1.62 ± 0.48 0.94 ± 0.19*
Female 84 54.9 ± 11.4 56.1±8.2 156.6±5.2 22.9±3.3 1.53 ± 0.49 0.88 ± 0.20
K/L grade 0 34 46.7 ± 11.3 63.9±12.9 163.1±10.3 23.8±3.1 1.42 ± 0.36 0.85 ± 0.18
I 61 55.1 ± 11.5 62.1±10.4 162.8±7.9 23.3±3.1 1.55 ± 0.45 0.88 ± 0.20
II 38 58.6 ± 10.5 63.7±14.2 164.1±9.0 23.5±4.1 1.61 ± 0.58 0.96 ± 0.19
III 33 60.6 ± 8.9 61.3±9.7 161.8±7.4 23.3±2.7 1.70 ± 0.51 0.97 ± 0.22
IV 0 - - - - - -
p-value <0.01** 0.738 0.741 0.916 0.065 0.037*
value =mean ± SD.
BW; body weight, HT; height, BMI; body mass index.
*; p < 0.05, **; p < 0.01.
Hong and Kong BMC Musculoskeletal Disorders 2013, 14:141 Page 4 of 9
http://www.biomedcentral.com/1471-2474/14/141the group of radiological OA and the differences were
statistically significant (p < 0.01 and p < 0.05, respectively)
(Table 2).
Age and 18F-FDG uptake values showed a consistent
increase with K/L grade of the knees. In addition, the
increase of joint-SUVmean was significantly specific for
bony changes and radiological OA of the knee.
18F-FDG uptake and clinical OA of knee joints
The joint-SUVmean and intra-articular SUVmax of knee
joints were analyzed according to OA-related symptoms
to determine whether the SUVs corresponded to clinical
manifestations. OA-related symptoms and signs included
knee joint pain, stiffness, crepitus, bony tenderness, and
enlargement of the knee according to ACR criteria. They
were counted from 0 to 5 in total. No symptoms were ob-
served in 104 knees; 26 knees had one symptom; 12 knees
had two symptoms; 12 knees had three symptoms; 10Table 2 The differences of joint-SUVmean and intra-articular
n Age (yr) BW (kg
Knee + Symptom† Total 62 57.5 ± 11.8 64.01 ±
Male 24 56.0 ± 11.8 70.91 ±
Female 38 58.5 ± 11.8** 59.7 ± 8.
Knee without Symptom Total 104 53.9 ± 11.5 61.8 ± 1
Male 58 55.6 ± 12.3 68.7 ± 1
Female 46 51.8 ± 10.1 53.2 ± 7
Knee + OA history 20 64.6 ± 6.8** 63.0 ± 6
Clinical§ + laboratory OA 36 61.6 ± 9.9** 64.1 ± 8
Clinical + Radiographic§§ OA 71 59.5 ± 9.8** 64.0 ± 1
value =mean ± SD.
BW; body weight, HT; height, BMI; body mass index.
†; knee joint pain, stiffness, crepitus, bony enlargement and tenderness.
§; ≥ 2 of the symptoms‡.
§§; with definite osteophytes (≥ K/L grade II).
*; p < 0.05, ** ; p < 0.01.
As compared with those of the sex-matched groups without symptom.
As compared with those of the groups without OA history, clinico-laboratory or clinknees had four symptoms, and two knees had five symp-
toms. The intra-articular SUVmax with no symptoms was
1.49 ± 0.40; 1.61 ± 0.62 with one symptom; 1.53 ± 0.48
with two symptoms; 1.77 ± 0.47 with three symptoms;
2.06 ± 0.59 with four symptoms; and 2.30 ± 0.42 with five
symptoms. Difference among the groups by symptom
count for OA was significant for BMI (p < 0.05) and the
intra-articular SUVmax (p < 0.01), but not for the joint-
SUVmean. However, the intra-articular SUVmax showed
strong correlation with the joint-SUVmean (r = 0.659,
p < 0.01) (Table 3, Figure 2).
Because knees with positive RF, ESR higher than 40
mm/h, and palpable warmth were excluded from this
study, those with more than two symptoms could be
diagnosed as clinical and laboratory knee OA according
to ACR criteria. Thirty six knees were included as clinical
and laboratory OA; the joint-SUVmean and intra-articular
SUVmax of the group were 0.99±0.23 and 1.80±0.54,SUVmax by the evidences for knee OA
) HT(cm) BMI (kg/m2) SUVmax SUVmean
1.1 162.6 ± 7.9 24.1 ± 3.3 1.73 ± 0.58** 0.95 ± 0.23
2.1 170.6 ± 5.5 24.2 ± 3.2 1.77 ± 0.60 0.92 ± 0.21
1** 157.6 ± 4.2 24.1 ± 3.4** 1.69 ± 0.57** 0.96 ± 0.24**
2.0 163.2 ± 8.9 23.1 ± 3.2 1.49 ± 0.40 0.89 ± 0.19
0.7 169.0 ± 6.4 23.9 ± 3.0 1.56 ± 0.41 0.95 ± 0.19
.1 155.8 ± 5.8 21.9 ± 2.9 1.40 ± 0.36 0.81 ± 0.15
.1 156.5 ± 2.9* 25.7 ± 2.7** 1.95 ± 0.57** 1.10 ± 0.24**
.1 162.3 ± 7.6 24.4 ± 2.9 1.80 ± 0.54** 0.99 ± 0.23**
1.1 162.7 ± 7.9 24.1 ± 3.3 1.67 ± 0.55* 0.96 ± 0.20**
ic-radiological OA.
Table 3 The differences in joint-SUVmean and intra-articular SUVmax according to OA symptom count of the knees
Symptom count of the knee joints
p-value
0 1 2 3 4 5
n 104 26 12 12 10 2
Age (yr) 53.9 ± 11.5 51.9 ± 12.0 58.0 ± 3.6 66.5 ± 4.9 56.4 ± 13.3 81.0 ± 0.0 0.01*
BW (kg) 61.8 ± 12.0 63.9 ± 14.5 66.5 ± 7.9 61.2 ± 8.8 64.2 ± 7.9 67.0 ± 0.0 0.744
HT(cm) 163.2 ± 8.9 163.2 ± 8.5 161.7 ± 8.4 163.8 ± 5.6 162.6 ± 9.1 155.0 ± 0.0 0.836
BMI (kg/m2) 23.1 ± 3.2 23.8 ± 3.8 25.4 ± 2.4 22.8 ± 2.8 24.3 ± 2.9 27.9 ± 0.0 0.04*
SUVmax 1.49 ± 0.40 1.61 ± 0.62 1.53 ± 0.48 1.77 ± 0.47 2.06 ± 0.59 2.30 ± 0.42 0.01*
SUVmean 0.89 ± 0.18 0.88 ± 0.20 0.99 ± 0.25 0.90 ± 0.16 1.06 ± 0.29 1.15 ± 0.07 0.051
value =mean ± SD.
BW; body weight, HT; height, BMI; body mass index.
*; p < 0.05.
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and 1.51±0.45 of the non-OA group of symptom count 0
and 1 (p < 0.05 and p < 0.01, respectively) (Table 2).
Twenty knees presented with a history of OA, the joint-
SUVmean and intra-articular SUVmax were 1.10±0.24
and 1.95±0.57, respectively. The values were significantly
higher, compared with 0.91±0.18 and 1.61±0.46, respect-
ively, of the group without history of OA (p < 0.01 for both
values) (Table 2).
The results may indicate that the increases of joint-
SUVmean and intra-articular SUVmax are consistent
with clinical and laboratory knee OA.Figure 2 The difference according to OA symptoms was significant in
positive correlation with the joint-SUVmean (A) in males (B) and females (CChanges of 18F-FDG uptake according to age and gender
Aging is one of the most important factors in development
of OA. As the ACR suggests age above 50 as a criterion
for diagnosis of OA, the values for 18F-FDG uptake were
evaluated according to age. The SUVmean of knee joints
showed a weak correlation with the advance of age
(r = 0.326, p < 0.01); however, the joint-SUVmean and
intra-articular SUVmax in knee joints over the age of 50
(n = 118, 0.94±0.20 and 1.64±0.50, respectively) were
significantly higher than those of knee joints under 50
(n = 48, 0.82±0.19 and 1.42±0.41, respectively) (p < 0.01
and p < 0.05, respectively) (Table 4, Figure 3).the intra-articular SUVmax. The intra-articular SUVmax showed
).
Figure 3 (See legend on next page.)
Hong and Kong BMC Musculoskeletal Disorders 2013, 14:141 Page 6 of 9
http://www.biomedcentral.com/1471-2474/14/141
(See figure on previous page.)
Figure 3 The SUVs were significantly correlated with age in OA. With increasing age, the Mean SUV of the knee joint increased
independently of the presence of joint problems (A, B). The joint-SUVmean and intra-articular SUVmax showed significant positive correlation
with age (C, D), even in the group without OA symptoms (E, F) and without evidence of radiographic OA (G, H). The SUVs adjusted for age and
gender showed remarkable and significant correlations, especially in females (I, J).
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knee were significantly higher than in those without
symptoms (p < 0.01, respectively). Knees with history of
OA had significantly higher BMI and height than those
without history of OA (p < 0.01, respectively) (Table 2).
As OA occurs more frequently in females, the intra-
articular SUVmax and joint-SUVmean of 18F-FDG of 82
knees from 41 males and 84 knees from 42 females were
evaluated for determination of the difference according to
gender. Mean ages of males and females were 55.7±12.1
and 54.9±11.4, respectively (p = 0.59). The SUVmean in
males was 0.94±0.19, significantly higher than 0.88±0.20
of females (p < 0.05). Even higher, the values showed no
change by aging in males (r = 0.204, p = 0.06; r = 0.008,
p = 0.297, respectively); however, in females, the joint
mean and intra-articular SUVmax showed a significant in-
crease in correlation with aging (r = 0.503, p < 0.01; r =
0.392, p < 0.01, respectively). The results may indicate
that metabolic alteration represented by changes of
18F-FDG uptake is prominent in females, which is
consistent with OA development in association with
aging and gender.
Adjusted by linear regression analysis for age and gen-
der, the 18F-FDG uptake showed an association of each
one-year increase in age with a 0.006 increase in joint-
SUVmean (β = 0.006, 95% CI, p < 0.01). The βcoefficient
of joint-SUVmean adjusted by age and gender in
clinico-laboratory and radiological OA was 0.008
(p = 0.002); female 0.009 (p = 0.008) and male 0.006
(p = 0.119), as compared with 0.002 (P = 0.287) in non-
OA; female −0.00005 (p = 0.99), male 0.003 (p = 0.271)
(Figures 3I,J). Results of the analyses indicated that
increased joint-SUVmean in OA was not by aging, and
joint-SUVmean in knee OA was related to aging, but
not in non-OA, meaning that the significant correlationsTable 4 The joint-SUVmean and intra-articular SUVmax of kn
n BW (kg)
Age (yr) Total ≥ 50 118 61.9 ± 11.2
< 50 48 65.6 ± 12.9 1
Male ≥ 50 54 67.6 ± 1.5
< 50 28 72.6 ± 1.9
Female ≥ 50 64 57.0 ± 1.1 1
< 50 20 53.4 ± 1.5
value =mean ± SD.
BW; body weight, HT; height, BMI; body mass index.
*; p < 0.05, **; p < 0.01.found between joint-SUVmean and clinic-laboratory and
radiological knee OA persist, as compared to non-OA.
Discussion
ACR criteria for diagnosis of OA require more than
three of the clinical-, radiological-, and laboratory cri-
teria. In this study, symptomatic knees that met the
ACR requirement for OA showed a significant increase
of 18F-FDG uptake, and metabolic alteration represented
by the change of SUVmean was consistent with a history
of knee OA and clinical-, radiological knee OA. The
intra-articular SUVmax showed positive correlation with
the joint-SUVmean and showed a significant increase in
association with joint symptoms indicating OA. The
joint-SUVmean showed a significant increase according
to the grades of radiological bony changes, and the
values were higher in clinical-, laboratory, and radio-
logical OA than those in non-OA.
PET provides molecular imagery of biochemical and
metabolic changes and is supposed to overcome the lim-
itations of anatomical imaging studies. Because it is able
to illuminate whole body, PET has been widely used for
detection and staging of malignancies. For PET imaging,
18F-FDG is one of the most commonly used radioiso-
topes. Because malignant tissues are active in metabol-
ism, increased glucose uptake can be reflected by 18F-
FDG uptake as a glucose analog [11]. Glucose taken up
by cells is metabolized to glucose-6-phosphate and then to
fructose-6-phosphate and fructose 1,6-biphosphonate;
however, 18F-FDG-6-phosphate accumulates in the cell,
which creates the images seen on the PET scan [12]. In-
creased metabolism associated with infection or inflam-
mation can also be detected by PET using 18F-FDG; this
allows for assessment for inflammatory bone and joint dis-
eases, such as rheumatoid arthritis, psoriatic arthritis, andee joints in the groups over and under the age of 50
HT(cm) BMI (kg/m2) Max SUV SUVmean
161.2 ± 7.8 23.7 ± 3.3 1.64±0.50* 0.94 ± 0.20**
67.3 ± 8.9** 22.9 ± 2.9 1.42 ± 0.41 0.82 ± 0.19
167.9 ± 0.8 23.9 ± 0.5 1.68 ± 0.51 0.97 ± 0.18
172.5 ± 1.1 24.3 ± 0.4 1.51 ± 0.43 0.90 ± 0.21
55.6 ± 0.5* 23.5 ± 0.4** 1.60 ± 0.50* 0.92 ± 0.21**
160.0 ± 1.6 20.9 ± 0.6 1.31 ± 0.36 0.72 ± 0.09
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and inflammatory changes; therefore, increasing 18F-FDG
uptake could be predicted in OA. Wandler et al., who
evaluated the pattern and value of 18F-FDG uptake in
shoulder joints, reported that the uptake pattern was dif-
fuse, including the whole joint in patients with OA [13].
Nakamura et al. reported that 18F-FDG uptake was up-
regulated in OA and generally accumulated in periarticu-
lar lesions [14].
Females are particularly prone to OA, with a risk twice as
high as that of males. This has been thought to be associ-
ated with estrogen deficiency after menopause, which
down-regulates the estrogen receptor on the surface of
chondrocytes, resulting in decreased synthesis of proteogly-
can [15-17]. In this study, the SUVmean of knee joints was
higher in males than in females, however, the changes of
the values increased in strong correlation with aging in fe-
males, but not in males. This finding might indicate that al-
though metabolic rate is higher in males than in females,
the metabolic alteration by aging may be remarkable in fe-
males, which is consistent with OA. The differences
according to age and gender showed agreement with the
higher incidence of OA in aging females than in males.
The glycolysis and pentose phosphate pathways are
major pathways of glucose metabolism, and the uronic
acid pathway and hexosamine biosynthetic pathways are
important for excretion of metabolites as glucuronides and
for synthesis of amino-sugars such as glycosaminoglycans
(GAGs) and proteoglycans (PGs). In addition to the meta-
bolic pathways, glucose uptake and metabolism can be
influenced by the oxygen tension of tissues, thus, decreased
tissue perfusion and hypoxia could affect glucose uptake
and metabolism by anaerobic glycolysis [18].
Intra-articular and peri-articular structures, including
synovium, subchondral bone, ligaments, and synovial fluid,
as well as cartilage, may be affected by and generate mech-
anical loads and soluble mediators directing chondrocytes
to activation, cartilage to breakdown, and joints to degener-
ation [19]. Intra-articular reactions are very important in
joint degeneration and pathogenesis of OA; therefore, be-
cause discrimination of the respective structures is difficult
using PET and CT images, this study adopted intra-
articular SUVmax for evaluation of the impact of focal
intra-articular reactions on OA. In the current study, the
SUVmean of knee joints for global joint metabolism might
contain SUVs from peri-articular and intra-articular struc-
tures, including subchondral bones, and the intra-articular
SUVmax for focal intra-articular reactions irrespective to
the structures might involve uptake by synoviums, liga-
ments, and menisci as well as cartilage.
This study has a specific limitation related to assessment of
bony changes of the knee. The K/L grading system of knee
joints was originally based on X-ray images, however, in this
study, K/L grades were used for the reconstructed CTimages of the knee joints [9]. Despite the limitation, the im-
ages discriminated bony changes in association with OA and
its severity. Even though the increase of joint-SUVmean can
be related to direct damage/pathology of articular structures
and it is not only related to aging, the change of joint-
SUVmean as an indicator for metabolic alteration of knee
joints is clearly correlated with presence and severity of pri-
mary OA and aging in OA, especially in females.
Conclusions
As a result of this study, it would be supposed that 18F-FDG
uptake of PET scan is increased in OA and is consistent
with development of OA. The clinical- and radiological evi-
dence for OA and severity of OA consistently showed cor-
relation with the increasing SUVs in association with aging
in OA. Early detection for the changes can be a benefit of
PET/CT in terms of OA. The 18F-FDG uptakes on PET/CT
imaging may have capability for early detection of changes
to OA beyond the radiological assessment that is critical to
preventing progression to irreversible joint failure.
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